Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT is well-positioned in the healthcare real estate industry with a diverse portfolio of high-quality medical facilities, including integrated senior health campuses, outpatient medical centers, and triple-net leased properties. The company's recent financial results have shown strong growth in net operating income, driven by its successful integrated senior health campus segment and strategic acquisitions. With a strong balance sheet and a pipeline of potential future transactions, American Healthcare REIT is poised for continued success and growth in the healthcare real estate market. Its efficient and profitable business model, along with a low implied cap rate compared to its industry peers, makes it an attractive investment opportunity.

Bears say

American Healthcare REIT is facing potential challenges in its SHOP segment, with 2026 SSNOI growth guidance of 15-19%. The company's occupancy setup into 2Q26 appears favorable, but there is concern about a difficult 2Q comp and potential operational headwinds. Additionally, the company's high exposure to skilled nursing beds raises concerns about headline risk and volatility. Despite recent equity issuances and expected earnings growth, the company's heavy reliance on its Trilogy properties and communication transparency are key risks to consider.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.